Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. Reorganizes, Cuts Costs

Published: May 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals. Dunsire exits as the company is seeking to merge operations around the globe and cut costs as it braces for a sales decline. Anna Protopapas, a Takeda executive vice president of business development who has been with the company since 1997, will replace Dunsire as president of Takeda’s Cambridge, MA-based cancer operation, effective immediately. Dunsire will also depart from Takeda’s board of directors at next month’s board meeting, just one year after she joined the board.

Help employers find you! Check out all the jobs and post your resume.

Back to news